Effect of rifampin with bio-enhancer in the treatment of newly diagnosed sputum positive pulmonary tuberculosis patients: A double-center study

OBJECTIVE: To compare a fixed-dose combination (FDC) of Rifampicin 450 mg, Isoniazid 300 mg, Pyrazinamide 1500 mg and Ethambutol 800 mg (usual care group) and regimen of Rifampicin 200 mg, Isoniazid 300 mg and piperine 10 mg along with Pyrazinamide 1500 mg and Ethambutol 800 mg (intervention care gr...

Descripción completa

Detalles Bibliográficos
Autores principales: Nageswari, A.D., Rajanandh, M.G., Uday, M.K.R.A., Nasreen, R.J., Pujitha, R.R., Prathiksha, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830140/
https://www.ncbi.nlm.nih.gov/pubmed/31720402
http://dx.doi.org/10.1016/j.jctube.2018.07.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830140/
https://www.ncbi.nlm.nih.gov/pubmed/31720402
http://dx.doi.org/10.1016/j.jctube.2018.07.002

Ejemplares similares